Joslin Diabetes Center, a teaching and research affiliate of Harvard Medical School, is a one-of-a-kind institution on the front lines of the world epidemic of diabetes — leading the battle to conquer diabetes in all of its forms through cutting-edge research and innovative approaches to clinical care and education.

Research Grants 1,807 show all


$23M
2016

$25.5M
2017

$14.7M
2018

$13.2M
2019

$991.1K
2020

Publications 3,392 show all

  • 124
    Insulin/metabolism
  • 87
    Diabetes Mellitus, Type 2/drug therapy
  • 83
    Receptor, Insulin/metabolism
  • 81
    Blood Glucose/metabolism
  • 81
    Diabetes Mellitus, Type 1/complications
  • 79
    Insulin Resistance
  • 78
    Muscle, Skeletal/metabolism
  • 76
    Diabetes Mellitus, Type 2/genetics
  • 74
    Insulin/pharmacology
  • 70
    Signal Transduction

Patents 350show all

  • 217
    A61K - Preparations for medical, dental, or toilet purposes
  • 101
    C12N - Microorganisms or enzymes
  • 94
    G01N - Investigating or analysing materials by determining their chemical or physical properties
  • 85
    C07K - Peptides
  • 60
    C12Q - Measuring or testing processes involving enzymes, nucleic acids or microorganisms
  • 39
    A01K - Animal husbandry
  • 17
    C12Y - Enzymes
  • 14
    A61B - Diagnosis
  • 10
    G16H - Healthcare informatics, i.e. information and communication technology [ict] specially adapted for the handling or processing of medical or healthcare data
  • 9
    Y02A - Technologies for adaptation to climate change

Clinical Trials 158show all

56N/A27Phase 225Phase 38Phase 2/Phase 38Phase 49Other

Web Documents 293show all

Joslin Diabetes Center has 293 documents.

Contact Information

One Joslin Place
Boston, MA 02215
United States

Overview

Total FundingEmployeesLast Funding DateStatus
$10,800,000501-10002012-01-25Operating

Crunchbase Investment Rounds

DateAmountRoundValuationLead InvestorOther Investors
2012-01-25$10,800,000Debt FinancingMassachusetts Life Sciences Center